Wahren delivers global-quality solutions with seamless local
access to leading pharma brands.

+91 93197 23685

info@wahren.in

Plot No. 57, Sector-155, Noida,
Uttar Pradesh – 201301
To help us connect you with the appropriate person, please provide a bit more information. Wahren values your privacy
and will use your data solely to address your request.
As Southeast Asia’s pharmaceutical sector experiences rapid transformation—driven by regulatory harmonization, innovation, and rising healthcare needs—CPHI South East Asia 2025 emerges as a pivotal platform for regional collaboration and growth.
For the first time ever, the event will be hosted in Kuala Lumpur, Malaysia, bringing together 8,000+ pharma professionals, 400+ international exhibitors, and a highly curated pool of buyers from across Asia and beyond. With such a diverse and influential gathering, CPHI South East Asia is set to become the region’s most impactful pharmaceutical event.
From Indonesia, Thailand, Vietnam, and the Philippines to Malaysia, ASEAN’s pharmaceutical markets are among the fastest-growing globally. Governments across the region are:
Investing in local manufacturing,
Reforming regulatory frameworks,
Creating fertile ground for global partnerships.
Malaysia, as the 2025 host nation, is strategically positioned to lead this growth. The country’s pharmaceutical market is projected to grow from RM11.2 billion in 2022 to RM15.5 billion by 2027, supported by the New Industrial Master Plan (NIMP) 2030. This initiative offers strong incentives for API, biologics, and vaccine production.
Situated between Singapore and Indonesia, Kuala Lumpur provides seamless access to key ASEAN markets—making it an ideal base for expansion, distribution, and strategic alliances.
(Sources: MIDA, MITI Malaysia | ASEAN Pharmaceutical Industry Report)
Tap into high-growth markets supported by government-led initiatives.
Gain first-mover advantage in a fresh, opportunity-rich business environment.
Connect directly with regional buyers, CDMOs, distributors, and partners.
Leverage pre-qualified matchmaking for high-value conversations.
Innovation Showcase
Discover advancements across the full pharma spectrum—APIs, generics, biologics, herbal medicine, delivery systems, packaging solutions, analytical tools, and cutting-edge machinery.
Conference Program
Learn from leading regulators, manufacturers, and market experts on themes like ASEAN market access, clinical trials, and regulatory harmonization.
Business Matchmaking
Engage in pre-arranged, high-impact meetings with verified buyers actively seeking solutions and collaborations.
Special Features
Experience International Pavilions, Sustainability Square, Pharma Quest competition, and more—each designed to spark innovation and foster meaningful partnerships.
As Southeast Asia’s pharmaceutical sector experiences rapid transformation—driven by regulatory harmonization, innovation, and rising healthcare needs—CPHI South East Asia 2025 emerges as a pivotal platform for regional collaboration and growth.
For the first time ever, the event will be hosted in Kuala Lumpur, Malaysia, bringing together 8,000+ pharma professionals, 400+ international exhibitors, and a highly curated pool of buyers from across Asia and beyond. With such a diverse and influential gathering, CPHI South East Asia is set to become the region’s most impactful pharmaceutical event.
From Indonesia, Thailand, Vietnam, and the Philippines to Malaysia, ASEAN’s pharmaceutical markets are among the fastest-growing globally. Governments across the region are:
Investing in local manufacturing,
Reforming regulatory frameworks,
Creating fertile ground for global partnerships.
Malaysia, as the 2025 host nation, is strategically positioned to lead this growth. The country’s pharmaceutical market is projected to grow from RM11.2 billion in 2022 to RM15.5 billion by 2027, supported by the New Industrial Master Plan (NIMP) 2030. This initiative offers strong incentives for API, biologics, and vaccine production.
Situated between Singapore and Indonesia, Kuala Lumpur provides seamless access to key ASEAN markets—making it an ideal base for expansion, distribution, and strategic alliances.
(Sources: MIDA, MITI Malaysia | ASEAN Pharmaceutical Industry Report)
Tap into high-growth markets supported by government-led initiatives.
Gain first-mover advantage in a fresh, opportunity-rich business environment.
Connect directly with regional buyers, CDMOs, distributors, and partners.
Leverage pre-qualified matchmaking for high-value conversations.
Innovation Showcase
Discover advancements across the full pharma spectrum—APIs, generics, biologics, herbal medicine, delivery systems, packaging solutions, analytical tools, and cutting-edge machinery.
Conference Program
Learn from leading regulators, manufacturers, and market experts on themes like ASEAN market access, clinical trials, and regulatory harmonization.
Business Matchmaking
Engage in pre-arranged, high-impact meetings with verified buyers actively seeking solutions and collaborations.
Special Features
Experience International Pavilions, Sustainability Square, Pharma Quest competition, and more—each designed to spark innovation and foster meaningful partnerships.